BIO Convention in China 2013 Speakers

  • Recommend
  • Tweet
  • Print
  • Email

Below is a list of the 2013 BIO Convention in China speakers.

For questions about programming, please contact Sondra Behan, Manager, Industry research and Programs, Business Development, Biotechnology Industry Organization at: sbehan@bio.org.

This page is updated frequently. Please check back regularly. 

Photo Name and Title Panel, Date, Time Location
Wen Aidong
Director
Drug Clinical Trial Department, the Fourth Military Medical University First Affiliated Hospital
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Wang Aipin
General Manager/Director of Drug Safety Evaluation Center
Peking Union Medical College, Chinese Academy of Medical Sciences
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Friedhelm Blobel, PhD
President & CEO
SciClone Pharmaceuticals
Dissecting China's Unmet Medical Needs
Tuesday, November 12, 2013, 1:30 p.m. - 2:25 p.m.
Room 405
James Cai
Vice President of Medical Affairs
Roche
Roadmap to Cultivate an Innovative Biologics Industry in China
Tuesday, November 12, 2013
1:00 p.m. - 4:25 p.m.
Room 402 A & B
Lianyong (Leon) Chen
Founder & Managing Partner
Frontline BioVentures
Early-Stage VC Funding in China
Wednesday, November 13, 2013
1:00 p.m. - 1:55 p.m
Room 405
Helen Chen
Director & Partner
L.E.K. Consulting
China's Private Health Care Industry
Wednesday, November 13, 2013
11:00 a.m. - 11:55 a.m.
Room 403
Joseph Cho
Managing Director
R&D-based Pharmaceutical Association Committee (RDPAC)
Roadmap to Cultivate an Innovative Biologics Industry in China
Tuesday, November 12, 2013
1:00 p.m. - 4:25 p.m.
Room 402 A & B
Chen Chunlin
Chairman
Shanghai Medicilon Inc
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Zuo Conglin
General Manager
Joinn Laboratories (Beijing)
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Jie Liu D’Elia, PhD
Executive Director, Business Development
Bristol-Myers Squibb
Case Studies: Partnering Models Between Chinese & Western Companies
Wednesday, November 13, 2013
1:00 p.m. - 1:55 p.m.
Room 403
Joseph Damond
Senior Vice President of International Affairs,
BIO
Roadmap to Cultivate an Innovative Biologics Industry in China
Tuesday, November 12, 2013
1:00 p.m. - 4:25 p.m.
Room 402 A & B
Samantha Du
Managing Director
Sequoia Capital China
 
China Biomedicine Clusters and Enterprises Investment and Collaboration
Wednesday, November 13, 2013
2:10 p.m. - 4:25 p.m. 
Room 403
Alan F. Eisenberg
Vice President, Federal Government Relations
Celgene Corp.
Fireside Chat (Moderator)
Wednesday, November 13, 2013
11:00 a.m. - 11:55 a.m.
Room 403
James C. Greenwood
President and CEO
Biotechnology Industry Organization
Keynote Speaker
Tuesday, November 12, 2013
9:15 a.m. - 10:25 a.m.
Auditorium
Syd Hanna
Partner
Elixir Ventures
China Biomedicine Clusters and Enterprises Investment and Collaboration
Wednesday, November 13, 2013
2:10 p.m. - 4:25 p.m. 
Room 403
Simon Harworth
CEO
Dynasty Biotechnology Limited
China Biomedicine Clusters and Enterprises Investment and Collaboration
Wednesday, November 13, 2013
2:10 p.m. - 4:25 p.m. 
Room 403
Susan Herbert, PhD
Head of Global BD & Strategy
Merck KGaA
Fireside Chat
Tuesday, November 12, 2013
11:00 a.m. - 11:55 a.m.
Room 403
Maykin Ho, PhD
Advisory Director
Goldman Sachs
China's Private Health Care Industry
Wednesday, November 13, 2013
11:00 a.m. - 11:55 a.m.
Room 403
Jay Inslee
Governor
Washington State
Keynote Speaker
Tuesday, November 12, 2013
9:15 a.m. - 10:25 a.m.
Auditorium
Annalisa Jenkins, MBBS, MRCP
Executive VP and Head of Global Research and Development 
Merck KGaA
Fireside Chat
Tuesday, November 12, 2013
11:00 a.m. - 11:55 a.m.
Room 403
Weishi Li
Partner
Covington & Burling LLP
Case Studies: Partnering Models Between Chinese & Western Companies
Wednesday, November 13, 2013
1:00 p.m. - 1:55 p.m.
Room 403
Howard Liang, PhD
Managing Director
Biotechnology Equity Research, Leerink Swann
State of Capital Markets in the US
Tuesday, November 12, 2013
3:00 p.m. - 3:55 p.m.
Room 405
Richard Lim
Partner
Omega Fund
China Biomedicine Clusters and Enterprises Investment and Collaboration
Wednesday, November 13, 2013
2:10 p.m. - 4:25 p.m. 
 
Room 403
Ko-Chung Lin, PhD
Founder & CEO
Pharmaessentia
Rare Diseases in China
Wednesday, November 13, 2013
11:00 a.m. - 11:55 a.m.
Room 405
Zeng Ling
General Manager
Quintiles China
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Mike Liu, PhD
Head of Global Business Development
HengRui Pharmaceuticals
Case Studies: Partnering Models Between Chinese & Western Companies
Wednesday, November 13, 2013
1:00 p.m. - 1:55 p.m.
Room 403
Peter Liu, MD
Director and Founder
Delta Health
China's Private Health Care Industry
Wednesday, November 13, 2013
11:00 a.m. - 11:55 a.m.
Room 403
Yuwen Liu
CEO
Suzhou bioBAY
Early-Stage VC Funding in China
Wednesday, November 13, 2013
1:00 p.m. - 1:55 p.m
Room 405
Gary F. Locke
Ambassador of the United States of America to the People’s Republic of China
 
Keynote Speaker
Tuesday, November 12, 2013
9:15 a.m. - 10:25 a.m.
Auditorium
Amir Naiberg
CEO
Yeda Research and Development Company Ltd., The Weizmann Institute of Science
Early Stage Licensing in China - Opportunities and Challenges
Wednesday, November 13, 2013
3:00 p.m. - 4:25 p.m.
Room 405
Bruno Osterwalder, MD
Senior VP, Senior Strategic Advisor Oncology, Global Drug Development and Medical
Merck Serono
Dissecting China's Unmet Medical Needs
Tuesday, November 12, 2013, 1:30 p.m. - 2:25 p.m.
Room 405
Li Qing
Director
Development Center for Medical Science and Technology, Ministry of Health
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Li Shi, PhD
CEO
Shanghai Zerun Biotech
Company Partnerships in Vaccine Development
Tuesday, November 12, 2013
11:00 a.m. - 11:55 a.m.
Room 405
Yu Shanjiang
Deputy Director
Development Center for Biotech, MoST
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Kelvin Shao
Chief Marketing Officer
Shanghai NewSummit Biopharma Group
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Jean-Denis Shu, MD
Medical Director
Sanofi Pasteur, China
Company Partnerships in Vaccine Development
Tuesday, November 12, 2013
11:00 a.m. - 11:55 a.m.
Room 405
Dr. Henry Sun
Vice President, Tasly Holding Group
CEO, Tasly Pharmaceuticals, Inc.
Fireside Chat
Tuesday, November 12, 2013
3:00 p.m. - 3:55 p.m.
Room 403
Dave Tapolczay
CEO
Medical Research Council Technology
China Biomedicine Clusters and Enterprises Investment and Collaboration
Wednesday, November 13, 2013
2:10 p.m. - 4:25 p.m. 
Room 403
David Thomas, CFA David Thomas, CFA
Director, Industry Research & Analysis
BIO
State of Capital Markets in the US
Tuesday, November 12, 2013
3:00 p.m. - 3:55 p.m.
Room 405
Hongguang Wang
Advisor, Deputy Director
Chinese Academy of Science and Technology for Development (CASTED), Ministry of Science and Technology( M0ST)
Roadmap to Cultivate an Innovative Biologics Industry in China
Tuesday, November 12, 2013
1:00 p.m. - 4:25 p.m.
Room 402 A & B
Jonathan Wang, PhD
Senior Managing Director
OrbiMed Healthcare Fund Management
Early-Stage VC Funding in China
Wednesday, November 13, 2013
1:00 p.m. - 1:55 p.m
Room 405
Lawrence Wang, MD
Managing Director
Primavera Capital Group
China's Private Health Care Industry
Wednesday, November 13, 2013
11:00 a.m. - 11:55 a.m.
Room 403
Zheng Weiyi
General Manager
Nanjing Kangke Nuode Pharmaceutical Technology Co, Ltd
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Russell Wilson
Senior Vice President, Business Development
Novavax
Dissecting China's Unmet Medical Needs
Tuesday, November 12, 2013, 1:30 p.m. - 2:25 p.m.
Room 405
Asish K. Xavier, PhD
Vice President, Venture Investments
J&J Development Corporation 
State of Capital Markets in the US
Tuesday, November 12, 2013
3:00 p.m. - 3:55 p.m.
Room 405
Wang Xiaodong, PhD
Director and Investigator
National Institute of Biological Sciences (NIBS)
Fireside Chat
Tuesday, November 12, 2013
1:30 p.m. - 2:55 p.m.
Room 403
Wang Xin
Chairman
Beijing Bionovo
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Grace Xu
Vice President, Product Development & Strategic Planning
Bristol-Myers Squibb
Dissecting China's Unmet Medical Needs
Tuesday, November 12, 2013, 1:30 p.m. - 2:25 p.m.
Room 405
Guo Yajun
Director 
National Engineering Center for Antibody Drug Research
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Zhao Yajun
Director
General China Center for Pharmaceutical International Exchange
Keynote Speaker 
Tuesday, November 12, 2013
9:15 a.m. - 10:25 a.m.
Auditorium
Huang Yangbin
Chief Technology Officer
Shanghai Newsummit Biopharma Group
Introduction & Clinical, Non-Clinical and CRO Panels
Wednesday, November 13, 2013
9:00 a.m. - 10:55 a.m.
Room 403
Wang Yinxiang, PhD
CEO and Chief Scientific Officer
Zhejiang Beta Pharma
Fireside Chat
Wednesday, November 13, 2013
11:00 a.m. - 11:55 a.m.
Room 405
Michael Yu
CEO
Innovent Biologics
Roadmap to Cultivate an Innovative Biologics Industry in China
Tuesday, November 12, 2013
1:00 p.m. - 4:25 p.m.
Room 402 A & B
Jerry Zeldis, MD, PhD
Chief Executive Officer
Celgene Global Health and Chief Medical Officer, Celgene Corporation
Rare Diseases in China
Wednesday, November 13, 2013
11:00 a.m. - 11:55 a.m.
Room 405
Jimmy Zhang, PhD
Managing Director, MSD Early Investments
Greater China, Merck & Co.
Early-Stage VC Funding in China
Wednesday, November 13, 2013
1:00 p.m. - 1:55 p.m
Room 405
Nick Zhang, PhD
China General Manager, Senior Vice President
Frontage Lab
Dissecting China's Unmet Medical Needs
Tuesday, November 12, 2013, 1:30 p.m. - 2:25 p.m.
Room 405
Bian Zhenjia
Assistant Minister
China Food and Drug Administration (CFDA)
Keynote Speaker
Tuesday, November 12, 2013
9:15 a.m. - 10:25 a.m.
Auditorium
Xiaoming Zou, PhD, Chief Business Officer, Eddingpharm Case Studies: Partnering Models Between Chinese & Western Companies
Wednesday, November 13, 2013
1:00 p.m. - 1:55 p.m.
Room 403